Accelerant
Accelerant's revenue rose 51.5% to $913 million in fiscal 2025. Its net margin was −147.3%, down from 3.8% a year earlier. Free cash flow was $404 million, down 46.3%. The diluted share count fell 4.7%.
Net margin is net income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on equity is net income as a share of shareholders' equity. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.
What Accelerant does
Accelerant runs the Accelerant Risk Exchange, a technology platform for specialty insurance. It connects specialty underwriters, typically managing general agents, which it calls Members, with Risk Capital Partners, such as insurers, reinsurers and institutional investors, that supply the money to back the policies.
For Members, it provides data and analytics, distribution management, operational help and committed underwriting capacity, so they can focus on underwriting. For Risk Capital Partners, it offers a diversified portfolio of specialty insurance premium that may be hard to reach elsewhere. Its core business is fee-based: the Risk Capital Partners pay it a fixed percentage, volume-based fee to source, manage and monitor the business Members write.
At the end of 2025 there were 280 Members and 95 Risk Capital Partners on the platform. Accelerant says its Risk Exchange has a limited operating history.
Its biggest risks, as it describes them
- A short operating history that makes its prospects hard to judge.
- Members leaving the exchange once their contracts end.
- Adding products with higher loss ratios, which could make the exchange less attractive to partners.
- A lower financial strength rating, which would cut the business it can write.
- Not improving its technology fast enough to stay attractive to Members.
Income statement
Accelerant lost money in fiscal 2025: a net loss of $1.3 billion.
Returns on capital
Balance sheet
Five years at a glance
| Fiscal year end | FY23 | FY24 | FY25 |
|---|---|---|---|
| Cash and short-term investments | 775 | 1,226 | 1,716 |
| Debt incl. finance leases | — | 121 | 121 |
| Net debt (negative means net cash) | — | −1,104 | −1,595 |
| Net debt to EBITDA | — | −15.6x | — |
| Debt to equity | — | — | 0.2x |
| Interest coverage | −3.0x | 3.6x | −120.3x |
| Current ratio | — | — | — |
| Quick ratio | — | — | — |
Cash flow
Projections
Project Accelerant's revenue, net income and earnings per share five years ahead in a bull, a base and a bear case with your own figures, and see the share prices your P/E estimates give them, or value it with a discounted cash flow model. Every projected figure is yours: it is not a forecast of ours.
Insider trades
Over the 12 months between November 20, 2025 and November 19, 2026, 1 insider bought $7,951 of Accelerant shares on the open market, and 6 insiders sold $31.5 million, $21.6 million of it under trading plans set up in advance.
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 18, 2026 | Nancy HasleyDirector | Sold | 175,492 | $19.89 | $3.5 million | Form 4 |
| Nov 16, 2026 | Nancy HasleyDirector | Sold | 54,508 | $19.89 | $1.1 million | Form 4 |
| Nov 13, 2026 | Nancy HasleyDirector | Sold | 270,000 | $19.88 | $5.4 million | Form 4 |
| Aug 21, 2026 | Karen Sue MeriwetherDirector | Sold | 542 | $19.62 | $10,634 | Form 4 |
| Aug 13, 2026 | Nancy HasleyDirector | Sold plan | 20,489 | $19.56 | $400,765 | Form 4 |
| Aug 11, 2026 | Francis James ONeillCo-Founder, Chief U/W Officer | Sold plan | 89,219 | $12.41 | $1.1 million | Form 4 |
| Aug 10, 2026 | Jeffrey L RadkeCo-Founder, CEO, Director, 10% owner | Sold plan | 80,000 | $12.09 | $967,200 | Form 4 |
| Aug 10, 2026 | Francis James ONeillCo-Founder, Chief U/W Officer | Sold plan | 63,616 | $12.07 | $767,845 | Form 4 |
| Aug 3, 2026 | Jeffrey L RadkeCo-Founder, CEO, Director, 10% owner | Sold plan | 80,000 | $12.06 | $964,800 | Form 4 |
| Jul 28, 2026 | Francis James ONeillCo-Founder, Chief U/W Officer | Sold plan | 104,647 | $14.56 | $1.5 million | Form 4 |
| Jul 27, 2026 | Francis James ONeillCo-Founder, Chief U/W Officer | Sold plan | 110,467 | $14.63 | $1.6 million | Form 4 |
| Jul 27, 2026 | Jeffrey L RadkeCo-Founder, CEO, Director, 10% owner | Sold plan | 95,223 | $14.60 | $1.4 million | Form 4 |
Indicators
Four widely used measures, worked out from the company's filings. The cutoffs are the ones their authors or users go by, not a verdict of ours.
| Indicator | FY24 | FY25 |
|---|---|---|
| Piotroski F-score | — | — |
| Rule of 40 | 199.8% | 95.7% |
| Altman Z'' | — | — |
| Accruals ratio | — | −24.9% |
The nine F-score tests
| Test | FY24 | FY25 |
|---|---|---|
| Net income is positive | — | Fail |
| Cash from operations is positive | Pass | Pass |
| Return on assets rose | — | — |
| Cash from operations exceeds net income | Pass | Pass |
| Debt fell relative to assets | — | — |
| Current ratio rose | — | — |
| Share count didn't rise | Fail | Pass |
| Gross margin rose | — | — |
| Revenue rose relative to assets | — | — |
| F-score | — | — |
Compare
Put Accelerant side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| Accelerant | FY25 | 51.5% | — | 44.2% | — | — | — | |
| Crawford | FY25 | −2.2% | — | 7.2% | 8.4% | 1.8x | — | Compare |
| Hagerty | FY25 | 17.3% | — | 13.3% | — | — | — | Compare |
| AIFU | FY25 | −58.2% | −7.0% | −3.5% | — | — | — | Compare |
| eHealth | FY25 | 4.1% | 12.0% | −5.0% | 7.5% | 0.5x | 4 | Compare |
3 years of figures
| Fiscal year | FY23 | FY24 | FY25 |
|---|---|---|---|
| Income statement | |||
| Revenue | 344 | 603 | 913 |
| Revenue growth | — | 75.2% | 51.5% |
| Gross profit | — | — | — |
| Research and development | — | — | — |
| Operating income | — | — | — |
| Net income | −64 | 23 | −1,345 |
| Diluted EPS (US$) | −0.29 | 0.14 | −7.49 |
| Diluted shares (millions) | 166 | 200 | 190 |
| Cash flow | |||
| Cash from operations | 290 | 786 | 445 |
| Capital expenditure | 33 | 34 | 41 |
| Free cash flow | 257 | 751 | 404 |
| Dividends paid | 0 | 0 | 0 |
| Share buybacks | 0 | 0 | 0 |
| Acquisitions | 3 | 0 | 10 |
| Stock-based compensation | 5 | 8 | 43 |
| Balance sheet at fiscal year end | |||
| Cash and short-term investments | 775 | 1,226 | 1,716 |
| Debt incl. finance leases | — | 121 | 121 |
| Total assets | — | 6,095 | 8,263 |
| Total liabilities | — | 5,668 | 7,537 |
| Shareholders' equity | — | 304 | 698 |
| Margins and ratios | |||
| Gross margin | — | — | — |
| Operating margin | — | — | — |
| Net margin | −18.6% | 3.8% | −147.3% |
| Free cash flow margin | 74.8% | 124.7% | 44.2% |
| Rule of 40 (growth + FCF margin) | — | 199.8% | 95.7% |
| Return on capital | — | — | — |
| Return on equity | — | — | −268.5% |
| Return on assets | — | — | −18.7% |
| Net debt to EBITDA | — | −15.6x | — |